STERIS Corporation Announces Date of Fiscal 2009 First Quarter Earnings Release and Conference Call
17 Julio 2008 - 3:52PM
PR Newswire (US)
MENTOR, Ohio, July 17 /PRNewswire-FirstCall/ -- STERIS Corporation
(NYSE: STE) today announced that it will issue its fiscal 2009
first quarter earnings before the market opens on July 30, 2008,
followed by a conference call at 10:00 a.m. Eastern time. The
conference call can be heard live over the Internet at
http://www.steris-ir.com/ or via phone by dialing 1-888-392-9976 in
the United States and Canada, and 1-517-645-6486 internationally,
then referencing the password "STERIS" and the conference leader's
name, "Julie Winter." For those unable to listen to the conference
call live, a replay will be available from 12:00 p.m. Eastern time
on July 30, 2008 until 5:00 p.m. Eastern time on August 13, 2008,
either over the Internet at http://www.steris-ir.com/ or via phone
by calling 1-800-756-3940 in the United States and Canada, and
1-402-998-0796 internationally. About STERIS The mission of STERIS
Corporation is to provide a healthier today and safer tomorrow
through knowledgeable people and innovative infection prevention,
decontamination and health science technologies, products and
services. The Company's more than 5,000 dedicated employees around
the world work together to supply a broad array of solutions by
offering a combination of equipment, consumables and services to
healthcare, pharmaceutical, industrial and government customers.
The Company is listed on the New York Stock Exchange under the
symbol STE. For more information, visit http://www.steris.com/ .
This news release and the conference call referenced here may
contain statements concerning certain trends, expectations,
forecasts, estimates, or other forward-looking information
affecting or relating to the Company or its industry that are
intended to qualify for the protections afforded "forward-looking
statements" under the Private Securities Litigation Reform Act of
1995 and other laws and regulations. Forward-looking statements
speak only as to the date of this report, and may be identified by
the use of forward-looking terms such as "may," "will," "expects,"
"believes," "anticipates," "plans," "estimates," "projects,"
"targets," "forecasts," "confidence," and "seeks," or the negative
of such terms or other variations on such terms or comparable
terminology. Many important factors could cause actual results to
differ materially from those in the forward-looking statements
including, without limitation, disruption of production or
supplies, changes in market conditions, political events, pending
or future claims or litigation, competitive factors, technology
advances, and changes in government regulations or the application
or interpretation thereof. Other risk factors are described in the
Company's Form 10-K and other securities filings. Many of these
important factors are outside STERIS's control. No assurances can
be provided as to any future financial results. Unless legally
required, the Company does not undertake to update or revise any
forward-looking statements even if events make clear that any
projected results, express or implied, will not be realized. Other
potential risks and uncertainties that could cause actual results
to differ materially from those in the forward-looking statements
include, without limitation, (a) the potential for increased
pressure on pricing that leads to erosion of profit margins, (b)
the possibility that market demand will not develop for new
technologies, products or applications, or the Company's business
initiatives will take longer, cost more or produce lower benefits
than anticipated, (c) the possibility that application of or
compliance with laws, court rulings, regulations, certifications or
other requirements or standards may delay or prevent new product
introductions, affect the production and marketing of existing
products, or otherwise affect Company performance, results, or
value, (d) the potential of international unrest or effects of
fluctuations in currencies, tax assessments or rates, raw material
costs, benefit or retirement plan costs, or other regulatory
compliance costs, (e) the possibility of reduced demand, or
reductions in the rate of growth in demand, for the Company's
products and services, and (f) the possibility that anticipated
cost savings may not be achieved, or that transition, labor,
competition, timing, execution, regulatory, governmental, or other
issues or risks associated with the matters described in the
referenced conference call may adversely impact Company
performance, results, or value. DATASOURCE: STERIS Corporation
CONTACT: Julie Winter, Manager, Investor Relations, of STERIS
Corporation, +1-440-392-7245 Web site: http://www.steris.com/
http://www.steris-ir.com/
Copyright